ProCE Banner Activity

CME

Video: Clinical Update on the Emerging Threat of Nontuberculous Mycobacterial Lung Disease

In this interactive, CME-certified video, gain expert insights on diagnosing and managing patients with nontuberculous mycobacterial lung disease.

Physicians: Maximum of 1.25 AMA PRA Category 1 Credits

Released: February 14, 2020

Expiration: February 13, 2021

No longer available for credit.

Share

Faculty

Stephen Ruoss

Stephen Ruoss, MD

Professor of Medicine
Pulmonary and Clinical Care
Stanford University Medical Center
Stanford, California

Kevin L. Winthrop

Kevin L. Winthrop, MD, MPH ID

Professor of Public Health
Professor of Infectious Diseases and Ophthalmology

OHSU-PSU School of Public Health
Oregon Health & Science University
Portland, Oregon

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Insmed

Partners

ATS

ProCE Banner

Target Audience

This program is intended for pulmonologists, infectious disease specialists, and other healthcare providers who care for patients with NTM-LD.

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Describe the clinical, radiographic, and microbiologic criteria for making an NTM-LD diagnosis
  • Compare and contrast current and emerging antimicrobial therapies for treatment-refractory NTM-LD regarding efficacy, safety, and adherence considerations

Disclosure

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any relevant conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

Faculty Disclosure

Primary Author

Stephen Ruoss, MD

Professor of Medicine
Pulmonary and Clinical Care
Stanford University Medical Center
Stanford, California

Stephen Ruoss, MD, has disclosed that he has received honoraria from Insmed.

Kevin L. Winthrop, MD, MPH ID

Professor of Public Health
Professor of Infectious Diseases and Ophthalmology

OHSU-PSU School of Public Health
Oregon Health & Science University
Portland, Oregon

Kevin L. Winthrop, MD, MPH ID, has disclosed that he has received funds for research support from Insmed and consulting fees from Horizon, Insmed, Johnson & Johnson, Paratek, and RedHill.

Staff Disclosure

Staff

Sharon Hwang, MD, MPH

Editorial Contributor

Sharon Hwang, MD, MPH, has no relevant conflicts of interest to report.

Kiran Mir-Hudgeons, PhD

Clinical Editor

Kiran Mir-Hudgeons, PhD, has no relevant conflicts of interest to report.

Zachary Schwartz, MSc, ELS

Scientific Director

Zachary Schwartz, MSc, ELS, has no relevant conflicts of interest to report.

Carolyn Skowronski, PharmD

Associate Director, Scientific Services

Carolyn Skowronski, PharmD, has no relevant conflicts of interest to report.

Instructions for Credit

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation

CCO designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Additional Information

Participation in this self-study activity should be completed in approximately 1.25 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from February 14, 2020, through February 13, 2021:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Program Medium

This program has been made available online.


Goal


The goal of this activity is to improve participants’ competence in applying current and emerging strategies in the diagnosis and treatment of patients with nontuberculous mycobacterial lung disease.